Nevada
|
1-11151
|
76-0364866
|
(State or other jurisdiction of incorporation or organization)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
1300 West Sam Houston Parkway South,
Suite 300, Houston, Texas
|
77042
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐ |
Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12)
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, $.01 par value
|
USPH
|
New York Stock Exchange
|
Emerging growth company ☐
|
|
Item 5.02 |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
|
• |
Objective Long-Term Incentive Plan for Senior Management for 2020
|
|
• |
Discretionary Long-Term Incentive Plan for Senior Management for 2020
|
|
• |
Objective Cash/RSA Bonus Plan for Senior Management for 2020
|
|
• |
Discretionary Cash/RSA Bonus Plan for Senior Management for 2020
|
ITEM 9.01
|
FINANCIAL STATEMENTS AND EXHIBITS
|
Exhibits
|
Description of Exhibits
|
99.1 |
U. S. Physical Therapy, Inc. Objective Long-Term Incentive Plan for Senior Management for 2020, effective March 3, 2020.
|
|
|
99.2 |
U. S. Physical Therapy, Inc. Discretionary Long-Term Incentive Plan for Senior Management for 2020, effective March 3, 2020.
|
|
|
99.3 |
U. S. Physical Therapy, Inc. Objective Cash/RSA Bonus Plan for Senior Management for 2020, effective March 3, 2020.
|
|
|
99.4 |
U. S. Physical Therapy, Inc. Discretionary Cash/RSA Bonus Plan for Senior Management for 2020, effective March 3, 2020.
|
U.S. PHYSICAL THERAPY, INC.
|
||
Dated: March 6, 2020
|
By:
|
/s/ Christopher J. Reading
|
Christopher J. Reading | ||
Chief Executive Officer
|
||
(duly authorized officer)
|
|
1. |
Corporate Leadership/Transition of CFO
|
|
2. |
Cost Control
|
|
3. |
Briotix Development
|
|
4. |
Same Store Growth/ Visit Growth
|
|
5. |
Compliance
|
|
6. |
Acquisitions
|
|
1. |
Briotix success, integration and forward progress
|
|
2. |
Cost Control at the clinic level and margin stability at Briotix
|
|
3. |
Development of West Team - Succession Planning
|
|
4. |
Compliance
|
|
5. |
Same Store Growth/ Visit Growth
|
|
6. |
Development of additional de novo facilities and tuck ins
|
|
1. |
Management Contract Development
|
|
2. |
Compliance
|
|
3. |
Development of East Team – Succession Planning
|
|
4. |
Same Store Growth/ Visit Growth
|
|
5. |
Development of additional de novo facilities and tuck ins
|
|
6. |
Cost Control
|
|
1. |
Corporate Leadership/Transition of CFO
|
|
2. |
Cost Control
|
|
4. |
Same Store Growth/ Visit Growth
|
|
5. |
Compliance
|
|
6. |
Acquisitions
|
|
1. |
Briotix success, integration and forward progress
|
|
2. |
Cost Control at the clinic level and margin stability at Briotix
|
|
3. |
Development of West Team - Succession Planning
|
|
4. |
Compliance
|
|
5. |
Same Store Growth/ Visit Growth
|
|
6. |
Development of additional de novo facilities and tuck ins
|
|
1. |
Management Contract Development
|
|
2. |
Compliance
|
|
3. |
Development of East Team – Succession Planning
|
|
4. |
Same Store Growth/ Visit Growth
|
|
5. |
Development of additional de novo facilities and tuck ins
|
|
6. |
Cost Control
|